The Glyburide Tablets, cataloged under National Stock Number 6505-01-258-7132, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. Government technical data includes 7 specifications, cited from the U.S. Government catalog. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. 1 item shares a part number with this NSN in the catalog (possible match — not a government interchangeability claim). Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-258-7132 |
| Item Name | Glyburide Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Status | ACTIVE |
| Therapeutic Equivalent | DIABETA BY HOECHST-ROUSSEL |
| Administration | ORAL |
| Primary Container Content Quantity | 60.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Features Provided | CHILD RESISTANT CLOSURE |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 5.000 MILLIGRAMS GLYBURIDE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Reference | Meaning |
|---|---|
| NDC00039-0052-06 | 3/9 Design control — primary reference Hoechst-Roussel Pharmaceuticals Inc |
| DIABETA | 5/9 Secondary reference Hoechst-Roussel Pharmaceuticals Inc |
| DIABETA TABLETS | 5/9 Secondary reference Hoechst-Roussel Pharmaceuticals Inc |
NSN 6505-01-258-7132 is a Glyburide Tablets, classified under FSC 6505, Drugs and Biologicals. Status: active.
1 possible match (shared part number, not a government interchangeability claim): 6505-01-259-1553. Verify interchangeability with system specifications before substitution.
Key specifications for 6505-01-258-7132: Therapeutic Equivalent: DIABETA BY HOECHST-ROUSSEL; Administration: ORAL; Primary Container Content Quantity: 60.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA. 7 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.